Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
Markus HechtMarkus EcksteinSandra RutznerJens von der GrünThomas IllmerGunther KlautkeSimon LabanMatthias G HautmannThomas B BrunnerBálint TamaskovicsAxel HinkeJian-Guo ZhouBenjamin FreyAnna-Jasmina DonaubauerIna BeckerSabine SemrauArndt HartmannPanagiotis BalermpasWilfried BudachUdo S GaiplHeinrich IroAntoniu-Oreste GostianRainer FietkauPublished in: Journal for immunotherapy of cancer (2022)
The trial was registered with ClinicalTrials.gov (identifier: NCT03426657). The trial was conducted as investigator-sponsored trial (IST).